This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China, Singapore.
The drug NITOZOL contains one active pharmaceutical ingredient (API):
1
|
UNII
R9400W927I - KETOCONAZOLE
|
|
Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101007 | Cream | Nitozol Cream CREAM 2% 15 g (in lami tube) | Cream. A white to off-white gelatinous homogenous mass | 28/08/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D01AC08 | Ketoconazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 45564 |
| NG | Registered Drug Product Database | A4-101007 |
| SG | Health Sciences Authority | 10369P, 10408P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.